One of the problems that has stemmed from the coronavirus pandemic is the current supply chain crisis. Suppliers of all kinds are facing dramatically increased demand, leading to major supply chain bottlenecks. Currently, one of the largest pain points in the industry is a lack of capacity among industry suppliers, particularly for single-use technology (SUT). This has led to reduced inventory and resulting interruptions in drug manufacturers’ timelines or unplanned downtimes.
This article reviews multi-site manufacturing and SUT, raises awareness for Security of Supply and business continuity management, and discusses the need to take action to benefit from multi-site manufacturing.